Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis
E Toussirot, D Wendling - Current opinion in rheumatology, 2007 - journals.lww.com
E Toussirot, D Wendling
Current opinion in rheumatology, 2007•journals.lww.comThe amino bisphosphonate pamidronate has shown clinical and radiological amelioration in
ankylosing spondylitis patients, although this improvement is mild and transient. Additional
studies are required to better define the real impact of pamidronate on ankylosing
spondylitis and its place among the different treatment options for the disease.
ankylosing spondylitis patients, although this improvement is mild and transient. Additional
studies are required to better define the real impact of pamidronate on ankylosing
spondylitis and its place among the different treatment options for the disease.
Summary
The amino bisphosphonate pamidronate has shown clinical and radiological amelioration in ankylosing spondylitis patients, although this improvement is mild and transient. Additional studies are required to better define the real impact of pamidronate on ankylosing spondylitis and its place among the different treatment options for the disease.
Lippincott Williams & Wilkins